Clinical Trial Update: This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis [Phase 4]

View source ↗

Summary

Phase 4 open-label, non-comparative trial assessing a short course of IV anidulafungin, with optional oral voriconazole, for candidemia and invasive candidiasis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Anidulafungin (anidulafungin)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Candidemia, Invasive Candidiasis | Phase 4 | Status: COMPLETED | Results posted: 2011-01-17